About
Timothy R. Wright has served on the Agenus board since 2006 and was Lead Director from 2009 to July 2025. He is currently President and CEO of BIORG, a human organoid company, and a faculty member of the Wake Forest Institute for Regenerative Medicine.
He previously served as CEO of MiMedx Group from May 2019 to September 2022 and as a Founding Partner of Signal Hill Advisors since February 2011, and has held senior global executive roles including Executive Vice President of Mergers and Acquisitions, Strategy and Innovation at Teva Pharmaceutical Industries and President of Covidien Mallinckrodt.
Roles
Agenus Inc.
Director · Current role
2006–present
BIORG
President and CEO · Human organoid company; current role
—
MiMedx Group
Chief Executive Officer · May 2019 to September 2022
2019–2022
Signal Hill Advisors, LLC
Founding Partner · Since February 2011
since 2011
Teva Pharmaceutical Industries Ltd.
Executive Vice President, Mergers and Acquisitions, Strategy and Innovation
—
Covidien Mallinckrodt
President
—
External Roles
Protagenic Therapeutics, Inc.
Director
—
Wake Forest Institute for Regenerative Medicine
Faculty member
—
Fixed Compensation
Performance Compensation
Director Compensation
FY 2025Fees Earned or Paid in Cash
$141,667
Option Awards
$57,787
BasisGrant-date fair value, ASC Topic 718
Total
$199,454
Also at Agenus Inc.
See how Top Bucket AI works for your firm
Request DemoTop Bucket AI Research
Stay ahead of private markets
Research and market intelligence for private-markets professionals.
✓
You're subscribed.
Thanks for signing up.